HURA vs NCLH · $125.1M cap vs P/E 16, rev $4.97B
TuHURA Biosciences Inc (HURA) versus Norwegian Cruise Line Holdings Ltd (NCLH) — a side-by-side from cached financials, not a winner call.
TuHURA Biosciences Inc (HURA) is a biotechnology company listed on US.
Norwegian Cruise Line Holdings Ltd (NCLH) is a travel services company listed on NYSE.
Latest reported HURA revenue for 2026-03-31 was $0. Net income was -$7.5M. HURA currently screens at market cap $125.1M.
Latest reported NCLH revenue for 2026-06-30 was $4.97B. Net income was $327.2M. NCLH currently screens at market cap $9.10B and trailing P/E 16.0.
HURA currently screens at market cap $125.1M. NCLH currently screens at market cap $9.10B and trailing P/E 16.0.
Not investment advice. Open the HURA and NCLH stock pages for the full models.
Not investment advice.